SRG-514

N/A

Report date: 2026/02/13 20:01:31

Base Information

Drug NameSRG-514
Drug Alias NameThermosensitive formulation of ketorolac (Surge Therapeutics)SRG-514
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSurge Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSurge Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A